- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/215 - Coronaviridae, p. ex. virus de la bronchite infectieuse aviaire
Détention brevets de la classe A61K 39/215
Brevets de cette classe: 2701
Historique des publications depuis 10 ans
34
|
29
|
27
|
18
|
36
|
428
|
566
|
606
|
483
|
163
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
The Regents of the University of California | 19784 |
51 |
BioNTech SE | 634 |
34 |
Modernatx, Inc. | 1258 |
32 |
Zoetis Services LLC | 1530 |
32 |
Novavax, Inc. | 161 |
28 |
The Wistar Institute of Anatomy and Biology | 446 |
24 |
Board of Regents, The University of Texas System | 5738 |
20 |
Institut Pasteur | 788 |
20 |
The Trustees of the University of Pennsylvania | 4295 |
18 |
Glaxosmithkline Biologicals S.A. | 1635 |
17 |
Inovio Pharmaceuticals, Inc. | 317 |
17 |
City of Hope | 977 |
16 |
Intervet Inc. | 895 |
16 |
Curevac SE | 263 |
16 |
The Board of Trustees of the Leland Stanford Junior University | 6329 |
14 |
Icahn School of Medicine at Mount Sinai | 929 |
14 |
Flagship Pioneering Innovations VI, LLC. | 427 |
14 |
HDT Bio Corp. | 49 |
14 |
Boehringer Ingelheim Vetmedica GmbH | 1263 |
13 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2832 |
13 |
Autres propriétaires | 2278 |